|Bid||1.12 x 1100|
|Ask||1.18 x 1100|
|Day's Range||1.1200 - 1.1800|
|52 Week Range||0.6800 - 3.1000|
|Beta (3Y Monthly)||0.83|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.50|
Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, announced today that it has initiated an early development program in corn to evaluate novel seed yield and drought tolerance traits. Corn is the highest value commercial row crop grown in the United States. Under this program, novel traits discovered by Yield10 will be deployed in corn by a third-party agriculture company with proven expertise introducing new traits into corn.
Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, today announced encouraging results from the Company’s 2018 Field Tests of C3003, a novel yield trait, in canola, Camelina and soybean. Yield10 is targeting step-changes of 10-20% in the evaluation and development of novel traits to increase seed yield in commercially important crops. In summary, the C3003 trait produced seed yield increases of up to 11% in the best lines of canola tested. Based on these results, the Company will progress C3003 in canola into the commercial development phase in 2019.
Yield10 Bioscience, Inc. (YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, today named Sherri M. Brown, Ph.D., as a special commercial and technical advisor to the Company, effective immediately. Dr. Brown is currently managing director of The Yield Lab, a global agrifood tech accelerator based in St. Louis.
Zero-debt allows substantial financial flexibility, especially for small-cap companies like Yield10 Bioscience Inc (NASDAQ:YTEN), as the company does not have to adhere to strict debt covenants. However, it also faces Read More...
Yield10 Bioscience Inc’s (NASDAQ:YTEN): Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for enhancing crop yield in the United States and Canada. The US$12.9m market-cap company’sRead More...
NEW YORK, NY / ACCESSWIRE / August 9, 2018 / Yield10 Bioscience, Inc. (NASDAQ: YTEN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 9, 2018 at 4:30 PM Eastern ...
LONDON, UK / ACCESSWIRE / July 2, 2018 / If you want a free Stock Review on VNTR sign up now at www.wallstequities.com/registration. This Monday, WallStEquities.com has initiated reports coverage on the following Specialty Chemicals equities: Venator Materials PLC (NYSE: VNTR), W. R. Grace & Co. (NYSE: GRA), Westlake Chemical Corp. (NYSE: WLK), and Yield10 Bioscience Inc. (NASDAQ: YTEN).
WOBURN, MA / ACCESSWIRE / May 29, 2018 / Yield10 Bioscience, Inc. (NASDAQ: YTEN), a company focused on developing new technologies to achieve step-change improvements to crop yield to enhance global food ...
Assessing Yield10 Bioscience Inc’s (NASDAQ:YTEN) performance as a company requires looking at more than just a years’ earnings data. Below, I will run you through a simple sense check toRead More...
Today, WallStEquities.com takes a look at the recent performance of Venator Materials PLC (NYSE: VNTR), W. R. Grace & Co. (NYSE: GRA), Westlake Chemical Corp. (NYSE: WLK), and Yield10 Bioscience Inc. (NASDAQ: YTEN). Stockton-On-Tees, the UK headquartered Venator Materials PLC's stock finished Thursday's session 0.27% lower at $18.37 with a total trading volume of 280,037 shares.